Trade IPSC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Century Therapeutics, Inc. (IPSC) is trading at US$2.03, down 9.19% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$374.83M. Over the past 52 weeks, IPSC has traded between US$0.44 and US$3.04. On Syfe you can trade IPSC with $0 commission and add it to your watchlist.
| Previous close | US$2.23 |
|---|---|
| Market cap | US$374.83M |
| 52-week range | US$0.44 – US$3.04 |
| Volume | 629.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Century Therapeutics, Inc.
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
Year: 2021
Mizuho Initiates Century Therapeutics at Outperform
Jun 4, 10:56 AM · MT Newswires
Update: Mizuho Initiates Century Therapeutics at Outperform With $8 Price Target
May 27, 10:54 AM · MT Newswires
Century Therapeutics, Inc. (IPSC) stock is trading at US$2.03, -9.19% from the previous close of US$2.23.
The market cap for Century Therapeutics, Inc. (IPSC) stock is approximately US$374.83M.
The 52-week high for Century Therapeutics, Inc. (IPSC) stock is US$3.04.
The 52-week low for Century Therapeutics, Inc. (IPSC) stock is US$0.44.
Century Therapeutics, Inc. (IPSC) does not currently pay a dividend.
Stay on top of IPSC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
